- Home
- JAZZ vs TTMI Comparison
JAZZ vs TTMI Comparison
Compare JAZZ & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- TTMI
- Stock Information
- Founded
- JAZZ 2003
- TTMI 1978
- Country
- JAZZ Ireland
- TTMI United States
- Employees
- JAZZ N/A
- TTMI N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- TTMI Electrical Products
- Sector
- JAZZ Health Care
- TTMI Technology
- Exchange
- JAZZ Nasdaq
- TTMI Nasdaq
- Market Cap
- JAZZ 8.2B
- TTMI 7.2B
- IPO Year
- JAZZ 2007
- TTMI 2000
- Fundamental
- Price
- JAZZ $141.45
- TTMI $63.41
- Analyst Decision
- JAZZ Strong Buy
- TTMI Strong Buy
- Analyst Count
- JAZZ 14
- TTMI 4
- Target Price
- JAZZ $179.71
- TTMI $65.50
- AVG Volume (30 Days)
- JAZZ 739.6K
- TTMI 2.4M
- Earning Date
- JAZZ 11-05-2025
- TTMI 10-29-2025
- Dividend Yield
- JAZZ N/A
- TTMI N/A
- EPS Growth
- JAZZ N/A
- TTMI 90.88
- EPS
- JAZZ N/A
- TTMI 1.26
- Revenue
- JAZZ $4,157,832,999.00
- TTMI $2,782,990,000.00
- Revenue This Year
- JAZZ $5.80
- TTMI $20.48
- Revenue Next Year
- JAZZ $6.06
- TTMI $9.21
- P/E Ratio
- JAZZ N/A
- TTMI $50.01
- Revenue Growth
- JAZZ 4.14
- TTMI 17.88
- 52 Week Low
- JAZZ $95.49
- TTMI $15.78
- 52 Week High
- JAZZ $148.06
- TTMI $71.85
- Technical
- Relative Strength Index (RSI)
- JAZZ 61.16
- TTMI 51.05
- Support Level
- JAZZ $128.80
- TTMI $67.15
- Resistance Level
- JAZZ $144.97
- TTMI $71.85
- Average True Range (ATR)
- JAZZ 4.65
- TTMI 3.86
- MACD
- JAZZ -0.13
- TTMI -0.10
- Stochastic Oscillator
- JAZZ 75.14
- TTMI 43.03
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.